Mckenna Mark C.
Reporting Owner SEC Filing List

CIK: 0001749623
FormFilerSubject CompanyFiling AgentDateActions
3Initial statement of beneficial ownershi...Mckenna Mark C.Edgaragents Llc /fa01/22/2026
3Initial statement of beneficial ownershi...Helix Acquisition Corp. IiiEdgaragents Llc /fa01/22/2026
4Statement of changes in beneficial owner...Newamsterdam Pharma Co N.v.Donnelley Financial Solutions /fa/01/09/2026
4Statement of changes in beneficial owner...Mckenna Mark C.Donnelley Financial Solutions /fa/01/09/2026
4Statement of changes in beneficial owner...Mckenna Mark C.Edgaragents Llc /fa08/11/2025
4Statement of changes in beneficial owner...Bridgebio Oncology Therapeutics, Inc.Edgaragents Llc /fa08/11/2025
4Statement of changes in beneficial owner...Mckenna Mark C.Toppan Merrill/fa06/20/2025
4Statement of changes in beneficial owner...Apogee Therapeutics, Inc.Toppan Merrill/fa06/20/2025
4Statement of changes in beneficial owner...Mckenna Mark C.Spyre Therapeutics, Inc. /fa06/02/2025
4Statement of changes in beneficial owner...Spyre Therapeutics, Inc.Spyre Therapeutics, Inc. /fa06/02/2025
Load More

Mckenna Mark C. 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned